SCHEMBL346306

SCHEMBL346306

C=CCCCCC(O)CO

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
USP2 O75604 5/20 0.59
ALDH1A1 P00352 5/20 0.46
MAPT P10636 3/20 0.46
CYP3A4 P08684 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 1/20 0.46
THRB P10828 1/20 0.42
TSHR P16473 3/20 0.37
ABCC4 O15439 1/20 0.37
LMNA P02545 4/20 0.36
RECQL P46063 1/20 0.36
LPAR3 Q9UBY5 2/20 0.32
LPAR2 Q9HBW0 1/20 0.32
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28438298 1.00 USP2 (0.59) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL3117959 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL4461000 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL816099 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL10027883 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL7737900 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL3114128 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL4457448 0.98 USP2 (0.62) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL3913910 0.93
SCHEMBL9308291 0.88 TSHR (0.59) USP2ALDH1A1MAPTCYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 780 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122094991-A Solution process for producing functionalized polyolefin 2026-05-26 CN claimed
US-20260062596-A1 SILANE-TERMINATED POLYMERS MERZ + BENTELI AG (CH) 2026-03-05 US claimed
US-20260028450-A1 SILANE-TERMINATED POLYMERS MERZ + BENTELI AG (CH) 2026-01-29 US claimed
EP-4337738-B1 HOT MELT ADHESIVE COMPRISING FUNCTIONALIZED POLYOLEFINS SABIC GLOBAL TECHNOLOGIES BV (NL) 2025-11-26 EP claimed
US-12384946-B2 Hot melt adhesive comprising functionalized polyolefins SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2025-08-12 US claimed
WO-2025078490-A1 SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2025-04-17 WO claimed
CN-115066288-B Method for coupling ligands to composite materials 默克密理博有限公司 2025-03-11 CN claimed
US-20250019470-A1 SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS SABIC GLOBAL TECHNOLOGIES BV (NL) 2025-01-16 US claimed
US-20250019469-A1 SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS SABIC GLOBAL TECHNOLOGIES BV (NL) 2025-01-16 US claimed
CN-119019654-A High-strength branched-chain type PBAT and preparation method thereof 清华大学 2024-11-26 CN claimed
EP-0957903-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Codon Pharmaceuticals, Inc. (US) 1999-11-24 EP claimed
US-5990177-A CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM CODON PHARMACEUTICALS, INC. (US) 1999-11-23 US claimed
EP-0926168-A1 Ethylen copolymers containing hydroxyl groups and fuel oils with improved lubricating activity Clariant GmbH (DE) 1999-06-30 EP claimed
EP-0922737-A1 Ink-jet inks comprising pigment precursors Hewlett-Packard Company (US) 1999-06-16 EP claimed
WO-1998055085-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-12-10 WO claimed
EP-0842250-A1 CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1998-05-20 EP claimed
WO-1998011882-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-03-26 WO claimed
US-5709737-A AQUEOUS LIQUID VEHICLE, COLORANT, ALCOHOL ADDITIVE; SUITABLE FOR MICROWAVE DRYING PROCESSES XEROX CORPORATION (US) 1998-01-20 US claimed
WO-1997003169-A1 CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO claimed
US-4973612-A TRIFUNCTIONAL ACRYLATE, UNSATURATED ALCOHOL OR ACID DOW CORNING CORPORATION (US) 1990-11-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062596-A1 SILANE-TERMINATED POLYMERS SMC4, PCNA, AKT1 USP2 2518/4885ALDH1A1 2752/4885MAPT 4776/4885
US-20260028450-A1 SILANE-TERMINATED POLYMERS ILK, AKT1, PCNA USP2 2631/4885ALDH1A1 3186/4885MAPT 4808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.